Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled… https://t.co/7Zu47vfZHF
LAMA added to combination LABA/ICS versus LABA/ICS for adults with asthma. https://t.co/YM3jTFDzg7
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @LungLead: Adding LAMA to LABA/ICS versus LABA/ICS in #asthma - benefits are limited. New Cochrane review here: https://t.co/qh4UYg4bHk
Adding LAMA to LABA/ICS versus LABA/ICS in #asthma - benefits are limited. New Cochrane review here: https://t.co/qh4UYg4bHk
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t.co/Sg32StJC4e 1/6
Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled… https://t.co/FdCT3GRMuE
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
Does adding tiotropium, a long-acting muscarinic antagonist (LAMA), to combination therapy… https://t.co/K2aq6voIwC
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
RT @CochraneAirways: New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t…
New review: LAMA+long-acting beta2-agonists & inhaled corticosteroids combo vs LABA/ICS for adult asthmatics https://t.co/I9QtqyYFX6 1/6
#Tiotropiumi saattaa vähentää oraalisen kortisonihoidon tarvetta vaikeassa #astma’ssa. #astmalääke #astmalääkkeet https://t.co/FzjrN09wRr